| 8 |
Immune repertoire and responses to neoadjuvant TCHP therapy in HER2-positive breast cancer |
관리자
| 2023-08-03 |
489 |
| 7 |
Tumor-infiltrating lymphocyte therapy: Clinical aspects and future developments in this breakthrough cancer treatment |
관리자
| 2023-08-03 |
458 |
| 6 |
The Association of Estrogen Receptor Activity, Interferon Signaling, and MHC Class I Expression in Breast Cancer |
관리자
| 2023-08-03 |
427 |
| 5 |
A New Human Leukocyte Antigen Typing Algorithm Combined With Currently Available Genotyping Tools Based on Next-Generation Sequencing Data and Guidelines to Select the Most Likely Human Leukocyte Antigen Genotype |
관리자
| 2023-08-03 |
476 |
| 4 |
Presence of tertiary lymphoid structures determines the level of tumor-infiltrating lymphocytes in primary breast cancer and metastasis |
관리자
| 2022-08-03 |
656 |
| 3 |
Expression of the MHC class II in triple-negative breast cancer is associated with tumor-infiltrating lymphocytes and interferon signaling |
관리자
| 2022-08-03 |
592 |
| 2 |
Expansion of tumor-infiltrating lymphocytes and their potential for application as adoptive cell transfer therapy in human breast cancer |
관리자
| 2022-08-03 |
632 |
| 1 |
A New Human Leukocyte Antigen Typing Algorithm Combined With Currently Available Genotyping Tools Based on Next-Generation Sequencing Data and Guidelines to Select the Most Likely Human Leukocyte Antigen Genotype |
관리자
| 2021-10-18 |
968 |